Related Experiment Video
Updated: Jun 5, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth
Jiqian Huang1, Luis C Matavelli, Helmy M Siragy
1Department of Medicine, Division of Endocrinology & Metabolism, University of Virginia Health System, Charlottesville, VA 22908-1409, USA.
Abstract:
1. Transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF) are expressed in renal glomeruli, and contribute to the development of diabetic nephropathy. Recently, we showed that (pro)renin receptor (PRR) is upregulated in the kidneys of the streptozocin (STZ)-induced diabetes rat model. We hypothesized that in the presence of hyperglycaemia, increased renal PRR expression contributes to enhanced TGF-β1-CTGF signalling activity, leading to the development of diabetic kidney disease. 2. In vivo and in vitro studies were carried out in Sprague-Dawley rats and rat mesangial cells (RMC). PRR blockade was achieved in vivo by treating STZ induced diabetes rats with the handle region peptide (HRP) of prorenin and in vitro by HRP or PRR siRNA in RMC. Angiotensin AT1 receptor blockade was achieved by valsartan treatment. 3. Results showed that expression of PRR, TGF-β1 and CTGF were upregulated in diabetic kidneys and RMC exposed to high glucose. Glucose exposure also induced PRR phosphorylation, a process that was inhibited by HRP, valsartan or PRR siRNA. HRP and valsartan significantly attenuated renal TGF-β1 and CTGF expression in diabetic animals and high glucose treated RMC. Similar results were observed in high glucose exposed RMC in response to PRR siRNA. TGF-β receptor blockade decreased CTGF expression in RMC. Combined administration of valsartan and PRR siRNA showed further reduction of TGF-β1 and CTGF expression in RMC. 4. In conclusion, PRR contributes to kidney disease in diabetes through an enhanced TGF-β1-CTGF signalling cascade.
Insights
The (pro)renin receptor (PRR) pathway exacerbates diabetic kidney disease by increasing transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF) signaling. Blocking PRR reduces these effects, offering a potential therapeutic target for diabetic nephropathy.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Diabetic nephropathy is characterized by renal fibrosis, involving transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF).
- The (pro)renin receptor (PRR) is upregulated in diabetic kidneys, suggesting a role in disease pathogenesis.
- Hyperglycemia is a key driver of diabetic kidney disease, potentially influencing PRR and downstream signaling.
Purpose of the Study:
- To investigate the role of PRR in high glucose-induced TGF-β1 and CTGF signaling in diabetic kidney disease.
- To determine if PRR blockade can attenuate the development of diabetic kidney disease.
- To elucidate the relationship between PRR, angiotensin AT1 receptor, and TGF-β1/CTGF pathways.
Main Methods:
- In vivo studies using streptozotocin (STZ)-induced diabetic rats treated with PRR blockade (handle region peptide - HRP) or valsartan.
- In vitro studies using rat mesangial cells (RMC) exposed to high glucose and treated with HRP, PRR siRNA, or valsartan.
- Assessment of PRR, TGF-β1, and CTGF expression, as well as PRR phosphorylation, in kidney tissues and RMC.
Main Results:
- PRR, TGF-β1, and CTGF were upregulated in diabetic kidneys and high glucose-treated RMC.
- High glucose induced PRR phosphorylation, which was inhibited by HRP, valsartan, and PRR siRNA.
- PRR blockade (HRP or siRNA) and valsartan significantly reduced renal and RMC TGF-β1 and CTGF expression.
Conclusions:
- PRR activation contributes to diabetic kidney disease by enhancing TGF-β1-CTGF signaling.
- Blocking PRR or the angiotensin AT1 receptor can attenuate TGF-β1 and CTGF upregulation in diabetes.
- PRR represents a potential therapeutic target for managing diabetic nephropathy.
Related Concept Videos
Diabetic Nephropathy
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
Hormonal Regulation
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Diabetic Retinopathy